For: | Compagnoni S, Bruno EM, Madonia G, Cannizzaro M, Madonia S. Direct antiviral agents in hepatitis C virus related liver disease: Don’t count the chickens before they’re hatched. World J Gastroenterol 2021; 27(21): 2771-2783 [PMID: 34135553 DOI: 10.3748/wjg.v27.i21.2771] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i21/2771.htm |
Number | Citing Articles |
1 |
Reham Hammad, Reda Badr Aglan, Shaymaa A. Mohammed, Eman Abu-elnasr Awad, Marwa A. Elsaid, Hanan M. Bedair, Seham K. Khirala, Mohamed A Selim, Asmaa A. Abo Elqasem, Areej Rushdi, Mohamed Ali, Omaima I. Abo-Elkheir, Eman F. Sanad, Nadia M. Hamdy. Cytotoxic T Cell Expression of Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) in Viral Hepatitis C-Mediated Hepatocellular Carcinoma. International Journal of Molecular Sciences 2022; 23(20): 12541 doi: 10.3390/ijms232012541
|
2 |
Zuzana Macek Jilkova, Komal Saleem, Samia Afzal, Thomas Decaens. Predictive Factors for Hepatocellular Carcinoma Development after Direct-Acting Antiviral Treatment of HCV. Livers 2021; 1(4): 313 doi: 10.3390/livers1040024
|
3 |
Jui-Ting Hsu, Ping-I Hsu, Chang-Bih Shie, Seng-Kee Chuah, I-Ting Wu, Wen-Wei Huang, Sheng-Yeh Tang, Kun-Feng Tsai, Li-Fu Kuo, Supratip Ghose, Jui-Che Hsu, Chih-An Shih. Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users. Medicina 2022; 58(3): 436 doi: 10.3390/medicina58030436
|